The main virulence factor of
Price
These results suggest that it is feasible to use a DNA-based immunization strategy against anthrax and any future anthrax vaccine should consider incorporation of a mutated ...
The main virulence factor of Bacillus anthracis is a toxin that consists of three separate gene products; protective antigen (PA), lethal factor (LF) and edema factor (EF). In July Infection and Immunity, Brian Price and colleagues from Ohio State University showed that DNA-based immunization with a plasmid encoding the LF or PA protein provides complete protection against anthrax lethal toxin.Price et al. used a gene gun to inoculate mice with either a vector plasmid encoding a fragment of PA o
The main virulence factor of
Price
These results suggest that it is feasible to use a DNA-based immunization strategy against anthrax and any future anthrax vaccine should consider incorporation of a mutated ...
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this IssueIn this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.
An improved chromatography membrane elution method helps scientists achieve higher yields of pure plasmid DNA.
By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
New fluidics and clog detection systems further simplify operation and reduce instrument downtime
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling